Epstein-Barr virus in non-Hodgkin's lymphomas of the upper respiratory tract: Association with sinonasal localization and expression of NK and/or T-cell antigens by tumour cells

Journal of Pathology

Volumn 178, Issue 3, 1996, Pages 297-302

  Kanavaros, Panagiotis ^b   Briere, Josette ^b   Lescs, Marie Claude ^b   Gaulard, Philippe ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b NONE

Author keywords

EBV ; sinonasal NHL; Waldeyer's ring NHL

Indexed keywords

T LYMPHOCYTE ANTIGEN;

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; NOSE; PARANASAL SINUS; PRIORITY JOURNAL; UPPER RESPIRATORY TRACT;

ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; KILLER CELLS, NATURAL; LYMPHOMA, NON-HODGKIN; PARANASAL SINUS NEOPLASMS; RNA, MESSENGER; RNA, VIRAL; T-LYMPHOCYTES; TONSILLAR NEOPLASMS; VIRAL MATRIX PROTEINS;

EID: 0029875435     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199603)178:3<297::AID-PATH469>3.0.CO;2-E     Document Type: Article

References (60)

1. Sullivan LJ. Epstem-Barr virus and lymphoproliferative disorders. Semin Hematol 1988; 25: 269-278
2. Young LS, Alfieri C, Hennessy K, et al. Expression of Epstem-Barr vtrus transformation-associated genes in tissues of patients with EBV lympho-proliferative disease. N Engt J Med 1989; 321: 1080-1089.
3. Hamilton-Dutoit SJ, Rea D, Raphael M, et al. Epstein-Ban virus latent gene expression and tumour cell phenotype in acquired immunodeficiency syndrome related non-Hodgkir's lymphoma. Am J Pathol 1993, 143: 1072-1085.
4. Anagnostopoulos I, Herbst H, Niedobitek G, Stein H. Demonstration of monoclonal EBV genomes in Hodgkn's disease and Ki-1 positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 1989; 74: 810-816.
5. Herbst H, Niedobitek G, Kneba M, et al High incidence of Epstcim-Barr virus genomes in Hodgkin's disease. Am J Pathol 1990; 137: 13-18.
6. Weiss LM, Movahed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. LV Engl J Med 1989; 320: 502-506
7. Jiwa NM, Kanavaros P, deBruin P, et al. Presence of Epstein-Barr virus harbouring small and intermediate sized cells in Hodgkin's disease. is there a relationship with Reed-Sternberg cells? J Pathol 1993; 169: 129-136.
8. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS Expression of Epstein-Barr virus latent gene products in the tumor cells of Hodgkin's disease. Lancet 1991; 337: 320-322.
9. Hamilton-Dutoit S, Pallesen G. A survey of Epstein-Barr gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas. Am J Pathol 1992; 335: 128-130.
10. Herbst H, Dallenbach F, Hummel M, et al. Epstein-Barr virus DNA and latent gene products in K.i-1 (CD30) positive anaplastic large cell lymphomas. Blood 1991; 78: 2666-2673.
11. Kanavaros P, Jiwa M, De Bruin P, et al. High incidence of EBV genome in CD30 positive non-Hodgkin's lymphomas. J Pathol 1992; 168: 307-315.
12. Ott G, Kirchner T, Seidl S, Muller-Hermelink HK. Primary gastric B-cell lymphoma is rarely associated with Epstein-Barr virus. Vtrchows Arch B [Cell Pathol] 1993; 64: 287-294.
13. Korbjuhn P, Anagnostopoulos I, Hummel M, et al. Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus negative European peripheral pleomorphic T-cell lymphomas. Blood 1993; 82: 217-223.
14. Luzi P, Leoncim I, Funto I, et al Epstein-Barr virus infection in sinonasal non-Hodgkin's lymphomas Virchows Arch 1994; 425: 121-125
15. Chan JKC, Yip TTC, Tsang WYW, et al. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol 1994; 18: 938-946
16. Gorp JV, Weiping L, Jacobse K, et al Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in western China. J Pathol 1994; 173: 81-87.
17. Ho PCS, Srivastava G, Loke SL. et al. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and T cell type. Hematol Oncol 1990, 8: 271-281.
18. Arber DA, Weiss LM, Albujar PF, Chen YY, Jaffe ES. Nasal lymphomas in Peru High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 1993; 17: 392-399.
19. Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990; 335: 128-130
20. Weiss LM, Gaffey MJ, Chen Y-Y, Frierson HF. Frequency of Epstein-Barr viral DNA in 'Western' sinonasal and Waldeyers ring non-Hodgkin's lymphomas. Am J Surg Pathol 1992; 16: 156-162.
21. Medeiros LJ, Jaffe ES, Chen Y-Y, Weiss LM Localization of Epstein-Barr viral genomes in angiocentnc immunoproliferative lesions. Am J Surg Pathol 1992. 16: 439-447.
22. Medeiros LJ, Peiper SC, Elwood L, Yano T, Rafleld M, Jaffe ES. Angiocentric immunoproliferative lesions' a molecular analysis of eight cases. Hum Pathol 1991; 22: 1150-1157.
23. Kanavaros P, Lescs MC, Briere J, et al. Nasal T-cell lymphoma. a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81: 2688-2695.
24. Borisch B, Hennig I, Laeng RH, et al. Association of Epstein-Barr virus with T-cell non-Hodgkm lymphoma of the midline granuloma type. Blood 1993: 82: 858-864.
25. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985; 43: 831-840.
26. Fahraeus R, Rymo L, Rhim JS, Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 1990; 345: 447-449
27. Dawson CW, Rickinson AB, Young LS Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 1990; 344: 777-780.
28. Henderson S, Rowe M, Gregory C, et al. Induction of Bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death Cell 1991; 65: 1107-1115.
29. The non-Hodgkin's Lymphoma Pathologic Classification project National Cancer Institute sponsored study of non-Hodgkin's lymphomas Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112-2135.
30. Stansfeld AG, Diebold J, Noel H, et al. Updated Kiel classification for lymphomas. Lancet 1988; 1: 292-293.
31. Cordel JL, Falim B, Erber W, et al. Immunoenzymatic labeling of antibodies using immune complexes of alkaline-phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Hislochem Cytochem 1984; 32: 219-229.
32. Sabourin JC, Kanavaros P, Briere J, et al. Epstein-Barr virus genomes and EBV-encoded latent membrane protein in pulmonary lymphomas occurring in non-immunocompromised patients. Am J Surg Pathol 1993: 17: 995-1002.
33. Young LS, Dawson CW, Clark D, et al, Epstein-Barr virus gene expression m nasopharyngeal carcinoma. J Gen Virot 1988; 6; 1051-1065
34. Niedobitek G, Young LS, Sam L, Brooks U, Prasad U, Rickinson AB Expresston of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinoma Am J Pathol 1992; 140: 879-885.
35. DeBruin PC, Jiwa NM, Van der Valk P. et al. Detection of Epstein-Bair virus nucleid acid sequences and protein in nodal T-cell lymphoma-, relation between latent membrane protein-1 positivity and clinical course Histopashology 1993; 23: 509-518.
36. Klein G Viral latency and transformation. The strategy of Epstein-Barr virus. Cell 1989; 58: 5-8
37. Knecht H, Bachmann E, Brousset P, el at Deletions within the LMP-1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and are identical to those observed in nasopharyngeal carcinoma. Blood 1993; 82: 2937-2942.
38. Ng CS, Chan JKC, Hui PK, Chan WC, Lo STH. Application of a T-cell receptor antibody βF1 for immunophenotypic analysis of malignant lymphomas. Am J Pathol 1988; 132: 365-371
39. Ng CS, Chan JKC. Lo STH Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum Pathol 1987; 18: 1257-1262
40. Gaulard P, Bourqelot P, Kanavaros P, et al. Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of /δ T-cell lymphomas. Am J Pathol 1990 ; 137: 617-623.
41. Kanavaros P, Farcet JP, Gaulard P, et al. Recombinative events of the T-cell antigen receptor δ gene in peripheral T-cell lymphomas. J Clin Invest 1991; 87: 666-671.
42. Suzumiya J, Takeshita M, Kimura N, el al. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas Blond 1994; 83: 2255-2260.
43. Lanier LL, Spits H, Phillips JH. The developmental relationship between NK cells and T cells. Immunol Today 1992; 13: 159-165
44. Soler J, Bordes R, Ortuno F, et al. Aggressive natural killer leukaemia/ lymphoma in two patients with lethal midline granuloma. Br J Haematol 1994; 86: 659-662.
45. Sanchez MJ, Muench MO, Roncarolo MG, Lanier LL, Phillips JH Identification of a common T/natural killer cell progenitor in human fetal thymus. J Exp Med 1994; 180: 569-576.
46. Tsang WYV, Chan JKC, Yip TTC, et al In situ localisation of Epstcin-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56 positive and CD56 negative T-cell lymphomas. Hum Pathol 1994; 25: 758-765.
47. Pan L, Diss TC, Peng H, et al. Epstein-Barr virus in enteropathy associated T-cell lymphoma J Pathol 1993; 170: 137-143
48. DeBruin PC, Jiwa NM, Oudejans J, et al. Presence of Epstein-Barr virus in extranodal T-cell lymphomas. differences in relation to site. Blood 1994; 83: 1612-1618.
49. Niedobitek G, Young LS Epstein-Barr virus persistence and virus-associated tumours Lancet 1994; 343: 333-335
50. Winther B, Innes DJ, Mills SE, et al. Lymphocyte subsets in normal airwa mucosa of the human nose Arch Otolaryngol Head Neck Surg 1987; 113: 59-62.
51. Robertson MJ, Ritz J Biology and clinical relevance of human natural killer cells. Blood 1990; 76: 2421-2438.
52. Kawa-Ha K, Inoue M, Sakata N, et al Chronic active EBV infection and splenic granular lymphocyte proliferative disorder Vth International Symposium on EBV and Associated Diseases. Annecy, France. 1992. H-Abstract Book, p 154
53. Hart D, Baker BW, Inghs MJ, et al Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukaemic cells. Blood 1992; 79: 2116-2123.
54. Kawa-Ha K, Ishihara S, Ninomiya T. L't al. CD3-negative lymphoprohfera-tive disease of large granular lymphocyte containing Epstein-Barr viral DNA J Clin Invest 1989; 84: 51-55
55. Gelb AB, van de Rijn M, Regula D, et al. Epstein-Barr virus associated natural killer large granular lymphocyte leukemia. Hum Pathol 1994; 25: 953-960.
56. Sixbey JW, Shirley P, Chesney PJ, Buntin DM, Resnick L. Detection of a second widespread strain of Epstein-Barr virus. Lancet 1989; 2: 761-763
57. Jones JF, Shurin S, Abramowsky C, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections N Engl J Med 1988; 318: 733-741.
58. Durkop H, Latza U, Hummel M, et al Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic of Hodgkin's disease. Cell 1992; 68: 421-430.
59. Smith CA, Gruss HJ, Davis T, et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF Cell 1993; 73: 1349-1356.
60. Gruss HJ, Botani N, Williams DE, et al. Pleotropic effects of the CD30 ligand on CD30 expressing cells and lymphoma cell lines Blood 1994; 83: 2045-2056